Genetic and epigenetic signatures associated with plasma oxytocin levels in children and adolescents with autism spectrum disorder
Open Access
- 7 January 2023
- journal article
- research article
- Published by Wiley in Autism Research
- Vol. 16 (3) , 502-523
Abstract
Oxytocin (OT), the brain's most abundant neuropeptide, plays an important role in social salience and motivation. Clinical trials of the efficacy of OT in autism spectrum disorder (ASD) have reported mixed results due in part to ASD's complex etiology. We investigated whether genetic and epigenetic variation contribute to variable endogenous OT levels that modulate sensitivity to OT therapy. To carry out this analysis, we integrated genome‐wide profiles of DNA‐methylation, transcriptional activity, and genetic variation with plasma OT levels in 290 participants with ASD enrolled in a randomized controlled trial of OT. Our analysis identified genetic variants with novel association with plasma OT, several of which reside in known ASD risk genes. We also show subtle but statistically significant association of plasma OT levels with peripheral transcriptional activity and DNA‐methylation profiles across several annotated gene sets. These findings broaden our understanding of the effects of the peripheral oxytocin system and provide novel genetic candidates for future studies to decode the complex etiology of ASD and its interaction with OT signaling and OT‐based interventions.Lay Summary: Oxytocin (OT) is an abundant chemical produced by neurons that plays an important role in social interaction and motivation. We investigated whether genetic and epigenetic factors contribute to variable OT levels in the blood. To this, we integrated genetic, gene expression, and non‐DNA regulated (epigenetic) signatures with blood OT levels in 290 participants with autism enrolled in an OT clinical trial. We identified genetic association with plasma OT, several of which reside in known autism risk genes. We also show statistically significant association of plasma OT levels with gene expression and epigenetic across several gene pathways. These findings broaden our understanding of the factors that influence OT levels in the blood for future studies to decode the complex presentation of autism and its interaction with OT and OT‐based treatment.Keywords
All Related Versions
Funding Information
- Autism Speaks (# 10136)
- National Institutes of Health (RFA‐HD 12–196, R01‐HD‐088007)
This publication has 147 references indexed in Scilit:
- Sensitive Parenting Is Associated with Plasma Oxytocin and Polymorphisms in the OXTR and CD38 GenesBiological Psychiatry, 2012
- Optimal Unified Approach for Rare-Variant Association Testing with Application to Small-Sample Case-Control Whole-Exome Sequencing StudiesThe American Journal of Human Genetics, 2012
- Modulation/physiology of calcium channel sub-types in neurosecretory terminalsCell Calcium, 2012
- Tyrosine hydroxylase and regulation of dopamine synthesisArchives of Biochemistry and Biophysics, 2011
- Association of oxytocin receptor (OXTR) gene variants with multiple phenotype domains of autism spectrum disorderJournal of Neurodevelopmental Disorders, 2011
- The association between oxytocin receptor gene (OXTR) polymorphisms and affective temperaments, as measured by TEMPS-AJournal of Affective Disorders, 2010
- mRNA and Protein Levels for GABAAα4, α5, β1 and GABABR1 Receptors are Altered in Brains from Subjects with AutismJournal of Autism and Developmental Disorders, 2010
- Expression of GABAB Receptors Is Altered in Brains of Subjects with AutismThe Cerebellum, 2008
- Structural Variation of Chromosomes in Autism Spectrum DisorderThe American Journal of Human Genetics, 2008
- Neonatal oxytocin manipulations have long-lasting, sexually dimorphic effects on vasopressin receptorsNeuroscience, 2007